RSV Vaccine Snapshot PRECLINICAL PHASE 1 Codagenix LiveAttenuated RSV Delta-G RSV NIH/NIAID/LID RSV ΔNS2 Δ1313 Medi-559, RSV NIH/NIAID/LID NanoBio Fraunhofer VLP Virosome Georgia State University Peptide microparticle VLP VLP Takeda Vaccines VLP VLP NIH/ NIAID/VRC DPX-RSV VLP VLP VLP RSV pre-F protein Instituto de Salud Carlos III RSV F Nanoparticle VLP University of Massachusetts Mucosis Nucleic Acid MARKET APPROVED RSV VLP Subunit PHASE 3 RSV cps2 BCG Agilvax Particlebased Medi-RSV ΔM2-2 SeV/RSV Pontificia Universidad Católica de Chile RSV WholeInactivated NIH/NIAID/LID PHASE 2 University of Illinois PeptiVir RSV peptides Renaptys SH protein University of Georgia RSV F protein RSV F protein RSV peptides RSV G protein RNA DNA RNA DNA MVA Adenovirus RSV F protein RSV F protein University of Saskatchewan RSV F protein RSV F protein BAVARIAN NORDIC Gene-based Vectors Alphavirus Crucell Sendai virus Combination MVA Adenovirus Fudan University DNA prime, Protein boost DNA+protein combo RuenHuei Biopharma Adenovirus Alphavirus Adenovirus/MVA University of Pittsburg Adenovirus Updated: July 8, 2014 Source http://sites.path.org/vaccinedevelopment/respiratory-syncytial-virus-rsv/
© Copyright 2024 ExpyDoc
